GlassScriptPhysician profile
Nathan C Condie
NPI 1861628430
$2,427.57
in general payments reported to CMS, 2019-2025
22 companies · $504 in 2025
The $504 reported for 2025 was more than what 79% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $271 · 2021: $126 · 2022: $383 · 2023: $196 · 2024: $409 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $776.86 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $613.10 | 2022-2025 | Botox |
| Allergan, INC. | $187.85 | 2019-2022 | |
| Si-Bone, INC. | $166.78 | 2024-2025 | |
| Abbott Laboratories | $114.84 | 2022-2025 | Proclaim |
| Vertos Medical, INC. | $88.31 | 2022-2023 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $78.42 | 2019-2020 | |
| Medtronic, INC. | $69.31 | 2023-2024 | Activos 10 Bone Cement |
| Pacira Pharmaceuticals Incorporated | $54.49 | 2021-2022 | |
| Globus Medical, INC. | $39.20 | 2025 | Senza |
| Amgen INC. | $27.23 | 2022 | |
| Bioventus LLC | $25.96 | 2024 | Supartz Fx Sodium Hyaluronate |
| Stratus Medical, LLC | $24.18 | 2023 | Nimbus |
| Lundbeck LLC | $22.94 | 2025 | Vyepti |
| Stimwave Technologies Incorporated | $21.88 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $20.54 | 2023 | Nuedexta |
| Medtronic USA, INC. | $18.54 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $16.73 | 2025 | |
| Averitas Pharma INC. | $16.27 | 2023 | Qutenza |
| Siemens Medical Solutions USA, INC. | $15.98 | 2025 | Cios Flow |
| Spr Therapeutics, INC | $15.07 | 2025 | Sprint Pns System |
| Avanos Medical | $13.09 | 2024 | Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Condie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.